Arvinas Stock (NASDAQ: ARVN) stock price, news, charts, stock research, profile.
Open | $32.590 |
Close | $31.950 |
Volume / Avg. | 426.276K / 752.729K |
Day Range | 31.893 - 33.230 |
52 Wk Range | 13.570 - 53.080 |
Market Cap | $2.186B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 13.31% |
Days to Cover | 15.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arvinas (NASDAQ: ARVN) through any online brokerage.
Other companies in Arvinas’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP), Neumora Therapeutics (NASDAQ:NMRA) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Arvinas (NASDAQ: ARVN) was reported by Wells Fargo on Thursday, May 9, 2024. The analyst firm set a price target for 60.00 expecting ARVN to rise to within 12 months (a possible 87.79% upside). 35 analyst firms have reported ratings in the last year.
The stock price for Arvinas (NASDAQ: ARVN) is $31.95 last updated May 9, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Arvinas.
Arvinas’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Arvinas.
Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.